Diabetes-related diabetic neuropathy (DN) has become a frequent and serious illness that requires early identification. In order to prevent the development of this syndrome and enhance patient outcomes, advanced diagnostic tools such skin biopsy, IENFD analysis, CCM, QST, and MRN have greatly increased the sensitivity and specificity of early detection procedures. While CCM offers a non-invasive in vivo assessment of small fibre neuropathy, QST evaluates the functional state of sensory nerves. The direct visualisation of tiny nerve fibres provided by skin biopsy combined with IENFD analysis enables the early diagnosis of neuropathic alterations. Early diagnosis of pathogenic changes is made easier by the thorough structural imaging of peripheral nerves provided by high-resolution ultrasonography and MRN. The incorporation of these technologies into clinical practice enhances the quality lifestyle for individuals with diabetes by facilitating individualised treatment programs and improving early detection. By analysing the effectiveness, advantages, and possible disadvantages of these innovative diagnostic methods for DN early diagnosis, this chapter emphasises the significance of these techniques in enhancing the management of diabetes.